Abstract：【Objective】 To investigate the expression of MMP and VEGF in primary renal cell carcinoma and its relationship with clinical features and prognosis of renal cell carcinoma. 【Methods】 A total of 72 cases of renal cell carcinoma confirmed by pathology in our hospital from January 2009 to June 2014 were selected, immunohistochemical staining was used to observe the expression of MMP-2, MMP-9 and VEGF in renal cell carcinoma, and the relationship between MMP-2, MMP-9 and VEGF expression and renal cell carcinoma was studied by unconditional Logistic regression. 【Results】 The expression of MMP-2,MMP-9,VEGF in renal cell carcinoma (RCC) increased gradually with the increase of TNM stage, and the difference was statistically significant among the different stages (P<0.05). In this group, 50 cases survived (the survival group), 22 cases died (the death group), the proportion of TNM stage Ⅰ-Ⅱ patients in the survival group was higher than that in death group (P<0.05). The expression of MMP2, MMP-9,VEGF in the dead group was significantly higher than that in the survival group (P<0.05). In TNM stage, MMP-2, MMP-9,VEGF was the main risk factor for the prognosis of renal cell carcinoma (OR=1.326, 1.559, 1.734, 1.846,P<0.05 ).【Conclusion】 The expression of MMP-2, MMP-9, VEGF in renal cell carcinoma is correlated with TNM stage and increases with the increase of TNM stage. MMP-2,MMP-9,VEGF are risk factors for the prognosis of renal cell carcinoma.
代宏亮, 杨静哲, 陈小均, 王成李. MMP与VEGF在原发肾癌组织中的表达及其与肾癌临床特征和预后的相关性[J]. 医学临床研究, 2018, 35(12): 2349-2351.
DAI Hong-liang, YANG Jing-zhe, CHEN Xiao-jun, et al. Expression of MMP and VEGF in Primary Renal Cell Carcinoma and its Relationship with Clinical Features and Prognosis of Renal Cell Carcinoma. JOURNAL OF CLINICAL RESEARCH, 2018, 35(12): 2349-2351.
2018, Vol. 35 
